Healthy volunteer trial. Intended indication: treatment of infections due to A. baumannii. research hub

A Phase 1 study to evaluate the effect of BV100 on the pharmacokinetics of polymyxin B in healthy volunteers

This early-stage clinical trial tests a new drug called BV100 alongside an existing antibiotic, polymyxin B. Researchers want to see how these medicines interact in healthy adults. The goal is to develop better treatments for hard-to-treat hospital infections caused by a bug called Acinetobacter baumannii.